跳至主要内容
临床试验/JPRN-UMIN000011424
JPRN-UMIN000011424已完成未知

Study of the effect of anagliptin on glucose and lipid metabolism abnormality after the test meal loading. - Study of the effect of anagliptin on glucose and lipid metabolism abnormality after the test meal loading.

Kanazawa Medical University0 个研究点目标入组 10 人开始时间: 2013年8月9日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients who used DPP-4 inhibitors within the last 3 months. 2. Patients with contraindication of anagliptin following: Patients who have a history of allergy due to anagliptin. Severe ketosis, diabetic coma or precoma, type I diabetes mellitus. Severe infection, before and after surgery, patients with severe trauma. 3. Patients on insulin. 4. Patients on rapid-acting insulin secretagogue. 5. Patients with severe renal failure and/or dialysis. 6. Patients with food allergy due to test meal component. 7. Patients who were judged to be inappropriate for the study by the investigator.

研究者

相似试验